Electromagnetic Navigation During Ultrasound Guided Foam Sclerotherapy for Venous Malformations

计划入组 30 人 · 首次发布于 2020 年 7 月 24 日

Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations

计划入组 135 人 · 首次发布于 2011 年 5 月 4 日

A Study of Enalapril in Treatment of Venous Malformations

计划入组 12 人 · 首次发布于 2025 年 3 月 25 日

PI3K-alpha inhibitor (vascular malformations)

Sulodexide

Rx

Naftidrofuryl

C₂₄H₃₃NO₃

Inari Medical

United States

Venus Concept

United States

VENUS REMEDIES LIMITED

India

Quoin Pharmaceuticals Achieves High-Concentration Topical Rapamycin Formulations for Rare Vascular Malformations

Palvella Therapeutics Appoints Rare Disease Commercial Expert Ashley Kline as Chief Commercial Officer

Palvella Therapeutics Advances QTORIN™ Rapamycin for Rare Genetic Skin Diseases